Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis. - Wikidata - awgldk - TriplyDB

Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.

Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.

http://www.wikidata.org/entity/Q33826145

about

Implication of decreased serum complement 3 in patients with diabetic nephropathy.Renal Tubular Complement 3 Deposition in Children with Primary Nephrotic Syndrome.

P2860

Q50086115-87F44E9F-E4C1-4B79-90ED-8B352C9DAC51 Q55555541-EF087C6A-A08C-4A10-AFBE-E2BF6295F28A

P2860

Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.

http://www.wikidata.org/entity/Q33826145

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.

@ast

Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.

@en

type

label

Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.

@ast

Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.

@en

prefLabel

Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.

@ast

Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.

@en

P1433

Q33826145-AB73BF5F-65E4-4484-9CA2-AB7A29520804

P1476

Q33826145-3E61A694-B549-4724-9BFE-8E016962BC3A

P2093

Q33826145-1E63D595-A10D-4A33-8EDC-DBCBA9D2750C

Q33826145-52207D9B-B881-4B2F-A5B2-7814D6DA821F

Q33826145-63255EC3-93BD-4A1A-8E45-3E096708A20B

Q33826145-66358330-8BF6-43EB-B0CF-F8D402669F61

Q33826145-755E103E-0248-4EA3-B1CD-787C281F106B

Q33826145-87787FFD-E8FA-45ED-B8EB-FFDED29E676F

Q33826145-C0313154-776A-422C-B93E-F23674D7F906

Q33826145-DA07F70C-CD95-40B0-84A5-9D29C4177143

P2860

Q33826145-01A9B1B7-0608-4E79-8508-7A4D46388993

Q33826145-053317A4-F69C-4CC8-817A-83869C7A5670

Q33826145-260FE4B2-89E5-490A-940D-C93C4FFA52CE

Q33826145-27DAC4DE-2858-4EF6-BC6A-DBD2CD74D5F3

Q33826145-29F2E6A4-834D-47EE-B275-3754DB6A9E6E

Q33826145-2C1C097D-F513-4621-A3E9-2E93381111A0

Q33826145-30EEEF4F-B2E5-4444-986B-6DD8BF87C0D1

Q33826145-3B433666-1798-4861-97C9-C39538FD1E4E

Q33826145-3B5C29A5-FDC1-4367-91A5-F72310E0CF82

Q33826145-543CC117-E631-4BC1-8C76-804B361A59C9

P2888

Q33826145-E3FDD8CD-D5FC-45DB-A5D1-E74AA73EBF22

P304

Q33826145-6F8D9DDD-ABA2-4E98-8C59-E02C203D93C9

P31

Q33826145-7C733791-5D52-4C9F-89FA-E4C22D79A36D

P356

Q33826145-0B8D4357-D4A2-4234-BE47-8842152019D0

P407

Q33826145-B3B72BE8-675F-457B-95B8-A007EA06F931

P433

Q33826145-439DF55C-C16D-4772-A64A-9318037A276A

P478

Q33826145-EB58D2EE-7607-49C7-8C02-E752CF48B2AB

P577

Q33826145-72820E28-04F6-4031-AD67-421A29B48DC6

P6179

Q33826145-B6288537-10CA-4BD6-9A32-469B35D13AC5

P698

Q33826145-F013C12E-FBBB-438C-84A7-8874F9EECC37

P921

Q33826145-1933A647-2D75-4411-8B68-1418C6F3BB11

P932

Q33826145-F9DE7890-721D-41D1-B093-BD64B0599AD3

P356

S41598-017-03344-1

P1433

Scientific Reports

P1476

Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.

@en

P2093

Hong Ren

http://www.w3.org/2001/XMLSchema#string

Jian Liu

http://www.w3.org/2001/XMLSchema#string

Jingyuan Xie

http://www.w3.org/2001/XMLSchema#string

Jun Tong

http://www.w3.org/2001/XMLSchema#string

Nan Chen

http://www.w3.org/2001/XMLSchema#string

Weiming Wang

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Zhang

http://www.w3.org/2001/XMLSchema#string

Xu Hao

http://www.w3.org/2001/XMLSchema#string

P2860

Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion

A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes.

Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States.

STEC-HUS, atypical HUS and TTP are all diseases of complement activation.

Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.

Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy.

Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy

P2888

s41598-017-03344-1

P304

4095

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-03344-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1086116726

http://www.w3.org/2001/XMLSchema#string

P698

28642464

http://www.w3.org/2001/XMLSchema#string

P921

glomerulosclerosis

P932

5481381

http://www.w3.org/2001/XMLSchema#string